These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 19001171)

  • 1. Frequent amyloid deposition without significant cognitive impairment among the elderly.
    Aizenstein HJ; Nebes RD; Saxton JA; Price JC; Mathis CA; Tsopelas ND; Ziolko SK; James JA; Snitz BE; Houck PR; Bi W; Cohen AD; Lopresti BJ; DeKosky ST; Halligan EM; Klunk WE
    Arch Neurol; 2008 Nov; 65(11):1509-17. PubMed ID: 19001171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.
    Perrotin A; Mormino EC; Madison CM; Hayenga AO; Jagust WJ
    Arch Neurol; 2012 Feb; 69(2):223-9. PubMed ID: 22332189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar amyloid correlates of preclinical cognitive decline.
    Stonnington CM; Chen K; Lee W; Locke DE; Dueck AC; Liu X; Roontiva A; Fleisher AS; Caselli RJ; Reiman EM
    Alzheimers Dement; 2014 Jan; 10(1):e1-8. PubMed ID: 23583233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
    Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
    JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
    Hatashita S; Yamasaki H
    J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study.
    Kemppainen N; Johansson J; Teuho J; Parkkola R; Joutsa J; Ngandu T; Solomon A; Stephen R; Liu Y; Hänninen T; Paajanen T; Laatikainen T; Soininen H; Jula A; Rokka J; Rissanen E; Vahlberg T; Peltoniemi J; Kivipelto M; Rinne JO
    Neurology; 2018 Jan; 90(3):e206-e213. PubMed ID: 29263220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
    Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
    Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.
    McNamee RL; Yee SH; Price JC; Klunk WE; Rosario B; Weissfeld L; Ziolko S; Berginc M; Lopresti B; Dekosky S; Mathis CA
    J Nucl Med; 2009 Mar; 50(3):348-55. PubMed ID: 19223409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
    Villemagne VL; Pike KE; Chételat G; Ellis KA; Mulligan RS; Bourgeat P; Ackermann U; Jones G; Szoeke C; Salvado O; Martins R; O'Keefe G; Mathis CA; Klunk WE; Ames D; Masters CL; Rowe CC
    Ann Neurol; 2011 Jan; 69(1):181-92. PubMed ID: 21280088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner.
    Gietl AF; Warnock G; Riese F; Kälin AM; Saake A; Gruber E; Leh SE; Unschuld PG; Kuhn FP; Burger C; Mu L; Seifert B; Nitsch RM; Schibli R; Ametamey SM; Buck A; Hock C
    Neurobiol Aging; 2015 Apr; 36(4):1619-1628. PubMed ID: 25702957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.